Department of Defense – pre-announcement of Parkinson’s Research Program (PRP) FY19

March 12, 2019 by ssw3an@virginia.edu

This e-mail is to notify the research community of recently released pre-announcement for the Parkinson’s Research Program (PRP) managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) https://cdmrp.army.mil/pubs/press/press to allow investigators time to plan and develop ideas for submission to the anticipated FY19 funding opportunities.

FY19 Focus Areas:

  • Clinical and research applications of digital health technology for Parkinson’s disease monitoring, including early identification.
  • Mechanisms of non-motor symptoms of Parkinson’s disease from basic biology to clinical application.
  • Sleep biology in Parkinson’s disease.
  • Quantifiable gene-environment interactions and the risk of Parkinson’s disease.

FY19 funding opportunities are anticipated for the following programs:

Investigator-Initiated Research Award

  • Independent investigators at or above the level of Assistant Professor (or equivalent).
  • Supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research and/or patient care.
  • Preliminary data to support feasibility are required. Any unpublished, preliminary data provided should originate from the laboratory of the Principal Investigator (PI) or a member(s) of the research team.
  • Preliminary data to support feasibility required.
  • Clinical trials not allowed.
  • Partnering PI Option:
    • Provides a higher level of funding to support synergistic partnerships between two or three independent investigators collaborating on a single application.
    • PIs are expected to demonstrate within the application the synergistic components that will significantly advance the project, such that the research outcomes could not otherwise be accomplished through the independent efforts of a single PI.
    • The proposed partnership should result in a level of productivity that is greater than that achievable by each PI independently.
  • Applications to this award mechanism must address at least one of the four FY19 Focus Areas.
  • Individual PI: maximum funding of $1.5 million (M) in total costs over a period of 3 years.
  • Partnering PI Option: maximum funding of $2.4 million (M) in total costs over a period of 3 years

Early Investigator Research Award

  • Postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree or residency training (or equivalent)
  • Verification of eligibility criteria must be provided in an Eligibility Statement signed by an appropriate institutional official and the PI.
  • The EIRA supports early-career investigators exploring innovative, high-impact ideas or new technologies applicable to Parkinson’s disease research and/or patient care. The PRP seeks applications from investigators working in a broad spectrum of disciplines including, but not limited to, basic science, engineering, bioinformatics, population science, translational research, and clinical research.
  • The application should demonstrate the PI’s potential for, and commitment to, pursuing a career in Parkinson’s disease research under the guidance of a designated Mentor(s). Evaluated criteria will include mentorship and mentorship environment with an identified path to independence.
  • Preliminary data not required.
  • Clinical trials not allowed.
  • Applications to this award mechanism must address at least one of the four FY19 Focus Areas.
  • Maximum funding of $360,000 in total costs over a period of 2 years

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcement.  FY19 pre-announcements can be found in the CDMRP home page features at https://cdmrp.army.mil.

Filed Under: Funding Opportunities